Article Details

First patient dosed in latest stage of AGILE COVID-19 drug trial

Retrieved on: 2021-04-20 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

First patient dosed in latest stage of AGILE COVID-19 drug trial. View article details on hiswai:

Excerpt

“We are excited to partner with GlaxoSmithKline and Vir Biotechnology in ... signals of antiviral activity and enhanced immune response to infection.”.

Article found on: www.miragenews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo